TSCHANTZ; Matt Aaron

Patent Applications and Registrations

Patent applications and USPTO patent grants for TSCHANTZ; Matt Aaron.The latest application filed is for "heteroaromatic compounds as btk inhibitors".

Company Profile

3.13.17

TSCHANTZ; Matt Aaron - Newtown CT
TSCHANTZ; Matt Aaron - Newton CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heteroaromatic Compounds As Btk Inhibitors App 20210009567 - BOSANAC; Todd ; et al.	2021-01-14
Heteroaromatic Compounds As Btk Inhibitors App 20200055843 - BOSANAC; Todd ; et al.	2020-02-20
Heteroaromatic Compounds As Btk Inhibitors App 20190092759 - BOSANAC; Todd ; et al.	2019-03-28
Heteroaromatic Compounds As Btk Inhibitors App 20180222893 - BOSANAC; Todd ; et al.	2018-08-09
Heteroaromatic compounds as BTK inhibitors Grant 9,975,882 - Bosanac , et al. May 22, 2	2018-05-22
Heteroaromatic Compounds As Btk Inhibitors App 20180030037 - BOSANAC; Todd ; et al.	2018-02-01
Heteroaromatic Compounds As Btk Inhibitors App 20170174663 - BOSANAC; Todd ; et al.	2017-06-22
Fused thiazin-3-ones as KCA3.1 inhibitors Grant 9,533,999 - Burke , et al. January 3, 2	2017-01-03
Fused Thiazin-3-ones As Kca3.1 Inhibitors App 20150232484 - Burke; Michael J. ; et al.	2015-08-20
Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides Grant 8,552,205 - Barbosa, Jr. , et al. October 8, 2	2013-10-08
Derivatives of 6,7-dihydro-5H-imidazo[1,2-.alpha.]imidazole-3-carboxylic acid amides Grant 8,481,750 - Kowalski , et al. July 9, 2	2013-07-09
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES App 20120178734 - Kowalski; Jennifer A. ; et al.	2012-07-12
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES App 20110224188 - Barbosa; Antonio Jose del Moral ; et al.	2011-09-15
Pyrimidine derivatives useful as inhibitors of PKC-theta Grant 7,601,714 - Barbosa, Jr. , et al. October 13, 2	2009-10-13
Substituted benzylimidazoles useful for the treatment of inflammatory diseases Grant 7,572,921 - Kim , et al. August 11, 2	2009-08-11
Pyrimidine Derivatives Useful as Inhibitors of Pkc-Theta App 20080318929 - Barbosa; Antonio J.M. ; et al.	2008-12-25
Pyridine derivatives useful as inhibitors of PKC-theta Grant 7,468,382 - Brunette , et al. December 23, 2	2008-12-23
Derivatives of [6,7-dihydro-5H-imidazo[1,2--a]imidazole-3-sulfonyl]-pyrrolidine-2-carbox- ylic acid amide Grant 7,462,637 - Kelly , et al. December 9, 2	2008-12-09
Pyrimidine Derivatives Useful As Inhibitors Of Pkc-theta App 20080287410 - BARBOSA; Antonio J.M. ; et al.	2008-11-20
Substituted Benzylimidazoles Useful For The Treatment Of Inflammatory Diseases App 20060252811 - Kim; Jin Mi ; et al.	2006-11-09
Pyridine Derivatives Useful As Inhibitors Of Pkc-theta App 20060217417 - Brunette; Steven Richard ; et al.	2006-09-28
Pyrimidine derivatives useful as inhibitors of PKC-theta App 20060025433 - Barbosa; Antonio J.M. JR. ; et al.	2006-02-02
Derivatives of [6,7-dihydro-5H- Imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrol- idine-2-carboxylic acid amide App 20050054704 - Kelly, Terence Alfred ; et al.	2005-03-10
Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxyl ic acid amide Grant 6,852,748 - Kelly , et al. February 8, 2	2005-02-08
Heterocyclic compounds useful as inhibitors of tyrosine kinases Grant 6,770,639 - Snow , et al. August 3, 2	2004-08-03
Heterocyclic compounds useful as inhibitors of tyrosine kinases App 20030166929 - Snow, Roger John ; et al.	2003-09-04
Heterocyclic compounds useful as inhibitors of tyrosine kinases Grant 6,506,769 - Snow , et al. January 14, 2	2003-01-14
Heterocyclic compounds useful as inhibitors of tyrosine kinases App 20020016460 - Snow, Roger John ; et al.	2002-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.